Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets

Mushtaq, Alia; Wu, Peng; Naseer, Muhammad Moazzam

doi:10.1016/j.pharmthera.2023.108579

Pharmacology & Therapeutics

2024

DOI: 10.1016/j.pharmthera.2023.108579

|View full text |Cite

Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets

Alia Mushtaq,

Peng Wu,

Muhammad Moazzam Naseer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

References 221 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Hybrid arginine-modified phospholipid nanotherapeutics based on multitarget quinoxalin-2-ones for cancer-cells delivery

Pashirova,

Mustakimova,

Nizameev

et al. 2024

Journal of Molecular Liquids

View full text Add to dashboard Cite

Hybrid arginine-modified phospholipid nanotherapeutics based on multitarget quinoxalin-2-ones for cancer-cells delivery

Pashirova,

Mustakimova,

Nizameev

et al. 2024

Journal of Molecular Liquids

View full text Add to dashboard Cite

Novel isatin–triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies

Mushtaq,

Asif,

Humayun

et al. 2024

RSC Adv.

Self Cite

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets

Cited by 2 publications

References 221 publications

Hybrid arginine-modified phospholipid nanotherapeutics based on multitarget quinoxalin-2-ones for cancer-cells delivery

Hybrid arginine-modified phospholipid nanotherapeutics based on multitarget quinoxalin-2-ones for cancer-cells delivery

Novel isatin–triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies

Contact Info

Product

Resources

About